Cargando…

A metabolic function of FGFR3-TACC3 gene fusions in cancer

Chromosomal translocations that generate in-frame oncogenic gene fusions are powerful examples of success of targeted cancer therapies(1–3). We discovered FGFR3-TACC3 (F3-T3) gene fusions in 3% of human glioblastoma(4). Subsequent studies reported similar frequencies of F3-T3 in many other cancers,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frattini, Véronique, Pagnotta, Stefano M., Tala, Fan, Jerry J., Russo, Marco V., Lee, Sang Bae, Garofano, Luciano, Zhang, Jing, Shi, Peiguo, Lewis, Genevieve, Sanson, Heloise, Frederick, Vanessa, Castano, Angelica M., Cerulo, Luigi, Rolland, Delphine C. M., Mall, Raghvendra, Mokhtari, Karima, Elenitoba-Johnson, Kojo S.J., Sanson, Marc, Huang, Xi, Ceccarelli, Michele, Lasorella, Anna, Iavarone, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771419/ https://www.ncbi.nlm.nih.gov/pubmed/29323298 http://dx.doi.org/10.1038/nature25171

Ejemplares similares

RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes
por: Mall, Raghvendra, et al.
Publicado: (2018)

Detection of statistically significant network changes in complex biological networks
por: Mall, Raghvendra, et al.
Publicado: (2017)

A map of tumor–host interactions in glioma at single-cell resolution
por: Caruso, Francesca Pia, et al.
Publicado: (2020)

FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium
por: Best, Sarah A., et al.
Publicado: (2018)

FGFR3-TACC3 fusion in solid tumors: mini review
por: Costa, Ricardo, et al.
Publicado: (2016)

FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma
por: Gött, Hanna, et al.
Publicado: (2022)

FGFR3–TACC3: A novel gene fusion in cervical cancer
por: Carneiro, Benedito A., et al.
Publicado: (2015)

FGFR3–TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle
por: Sarkar, Sourav, et al.
Publicado: (2017)

Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
por: Mata, Douglas A., et al.
Publicado: (2020)

Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases
por: Ballester, Leomar Y., et al.
Publicado: (2019)

Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
por: Tamura, Ryo, et al.
Publicado: (2018)

Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling
por: Nelson, Katelyn N., et al.
Publicado: (2018)

Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion
por: Métais, Alice, et al.
Publicado: (2023)

Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy
por: Migliozzi, Simona, et al.
Publicado: (2023)

RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine
por: Parker Kerrigan, Brittany C, et al.
Publicado: (2020)

Aberrations of TACC1 and TACC3 are associated with ovarian cancer
por: Lauffart, Brenda, et al.
Publicado: (2005)

Histology-specific FGFR2 alterations and FGFR2-TACC2 fusion in mixed adenoid cystic and neuroendocrine small cell carcinoma of the uterine cervix
por: Gill, Corey M., et al.
Publicado: (2020)

Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples
por: Kurobe, Masahiro, et al.
Publicado: (2016)

Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis
por: Lombardi, Benedetta, et al.
Publicado: (2017)

FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling
por: Daly, C, et al.
Publicado: (2017)

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability
por: Wang, Clark G., et al.
Publicado: (2023)

Successful Treatment and Retreatment With Erdafitinib for a Patient With FGFR3-TACC3 Fusion Squamous NSCLC: A Case Report
por: Pham, Chi, et al.
Publicado: (2023)

TACC3 in personalized medicine
por: Murata, Stephen, et al.
Publicado: (2015)

Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2017)

A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas
por: Rosenberg, Shai, et al.
Publicado: (2018)

massiveGST: A Mann–Whitney–Wilcoxon Gene-Set Test Tool That Gives Meaning to Gene-Set Enrichment Analysis
por: Cerulo, Luigi, et al.
Publicado: (2022)

An ID2-dependent mechanism for VHL inactivation in cancer
por: Lee, Sang Bae, et al.
Publicado: (2016)

EGFR mutations in sinonasal squamous tumors: oncogenic and therapeutic implications
por: Udager, Aaron M., et al.
Publicado: (2015)

Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine
por: Tong, Zhou, et al.
Publicado: (2020)

Stage 4 pancreatic adenocarcinoma harbouring an FGFR2-TACC2 fusion mutation with complete response to erdafitinib a pan-fibroblastic growth factor receptor inhibitor
por: Poon, Donald, et al.
Publicado: (2021)

Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF/FGFR Aberrations: A Phase I Dose-Expansion Study
por: Meric-Bernstam, Funda, et al.
Publicado: (2022)

Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription
por: Lee, Sang Bae, et al.
Publicado: (2022)

Pancancer network analysis reveals key master regulators for cancer invasiveness
por: Jethalia, Mahesh, et al.
Publicado: (2023)

Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer
por: Abate, Francesco, et al.
Publicado: (2014)

TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
por: Ha, Geun-Hyoung, et al.
Publicado: (2013)

TACC3 Is Important for Correct Progression of Meiosis in Bovine Oocytes
por: Mahdipour, Mahdi, et al.
Publicado: (2015)

TACC diagnosed by transoesophageal endoscopic ultrasonography: A case report
por: Pu, Xiao-Xin, et al.
Publicado: (2023)

Single-cell transcriptome analysis of lineage diversity in high-grade glioma
por: Yuan, Jinzhou, et al.
Publicado: (2018)

Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review
por: Broggi, Giuseppe, et al.
Publicado: (2022)

IDH Mutations: Genotype-Phenotype Correlation and Prognostic Impact
por: Wang, Xiao-Wei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g8hsbf4u4c1e26h7gb5bmk43ul